ScienceTechyNews: New BioIVT research on botanical-drug interactions published in Applied In Vitro Toxicology

This study investigates the potential for clinically-relevant botanical-drug interactions (BDIs) with Boswellia serrata (Indian Frankincense), a botanical that is used as an anti-inflammatory supplement. The popularity of products containing B. serrata extract is growing. US retail sales of B. serrata reached $14.6 million in 2017 and it continues to move up the top 40 list of best-selling herbal supplements; it is currently ranked number 19.

by